ZYMAXID Israel - English - Ministry of Health

zymaxid

allergan israel ltd - gatifloxacin 0.5 %w/v - ophthalmic solution - gatifloxacin - zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: aerobic gram- negative bacteria : haemophilus influenzae, aerobic gram-positive bacteria: staphylococcus aureus, staphylococcus epidermidis, streptococcus mitis group*, streptococcus oralis *, streptococcus pneumoniae. efficacy for this organisms was studied in fewer than 10 infections.

ZYMAR OPHTHALMIC SOLUTION 0.3% Singapore - English - HSA (Health Sciences Authority)

zymar ophthalmic solution 0.3%

abbvie pte. ltd. - gatifloxacin - solution - 3 mg/ml - gatifloxacin 3 mg/ml

TYMER 0.3% EYE DROP Eye drops Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

tymer 0.3% eye drop eye drops

jamjoom pharmaceuticals company, saudi arabia - gatifloxacin - eye drops - 0.3 %

ZYMAR 0.3% OPHTHALMIC SOLUTION Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

zymar 0.3% ophthalmic solution

allergan pharmaceuticals ltd - gatifloxacin - ophthalmic solution - 0.3 %

Gatistar as Sesquihydrate 0.3% Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

gatistar as sesquihydrate 0.3%

مستودع ادوية النابلسي - nabulsi drug store - gatifloxacin as sesquihydrate 0.3 % - as sesquihydrate 0.3%